About Aetna (NYSE:AET)
Aetna Inc. is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers' compensation administrative services and health information technology (HIT) products and services. The Health Care segment consists of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an Insured basis and an employer-funded basis, and emerging businesses products and services. The Group Insurance segment includes group life insurance and group disability products. Its products are offered on an Insured basis.
Industry, Sector and Symbol
Industry Managed Health Care
Sub-IndustryManaged Health Care
Trailing P/E Ratio34.9981515711645
Forward P/E Ratio19.36
Sales & Book Value
Annual Sales$63.16 billion
Price / Sales0.98
Cash Flow$10.54 per share
Price / Cash17.97
Book Value$51.13 per share
Price / Book3.70
Net Income$2.27 billion
Return on Equity21.84%
Return on Assets5.80%
Aetna (NYSE:AET) Frequently Asked Questions
What is Aetna's stock symbol?
Aetna trades on the New York Stock Exchange (NYSE) under the ticker symbol "AET."
How often does Aetna pay dividends? What is the dividend yield for Aetna?
Aetna declared a quarterly dividend on Monday, December 4th. Shareholders of record on Thursday, January 11th will be paid a dividend of $0.50 per share on Friday, January 26th. This represents a $2.00 dividend on an annualized basis and a yield of 1.06%. The ex-dividend date of this dividend is Wednesday, January 10th. View Aetna's Dividend History.
How will Aetna's stock buyback program work?
Aetna declared that its Board of Directors has approved a stock repurchase program on Friday, April 7th 2017, which permits the company to repurchase $4,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 98% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's leadership believes its stock is undervalued.
How were Aetna's earnings last quarter?
Aetna Inc (NYSE:AET) issued its earnings results on Tuesday, October, 31st. The company reported $2.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.06 by $0.39. The company had revenue of $14.99 billion for the quarter, compared to analysts' expectations of $15.12 billion. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The company's revenue for the quarter was down 5.0% compared to the same quarter last year. During the same period in the prior year, the business earned $2.07 earnings per share. View Aetna's Earnings History.
When will Aetna make its next earnings announcement?
What guidance has Aetna issued on next quarter's earnings?
Aetna issued an update on its FY17 earnings guidance on Tuesday, October, 31st. The company provided earnings per share (EPS) guidance of ~$9.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $9.56.
Where is Aetna's stock going? Where will Aetna's stock price be in 2018?
21 brokers have issued 1 year price targets for Aetna's stock. Their predictions range from $135.00 to $212.00. On average, they expect Aetna's share price to reach $178.59 in the next twelve months. View Analyst Ratings for Aetna.
What are Wall Street analysts saying about Aetna stock?
Here are some recent quotes from research analysts about Aetna stock:
- 1. According to Zacks Investment Research, "Aetna’s third-quarter earnings surpassed the Zacks Consensus Estimate and grew year over year, driven by strong underwriting margin performance, disciplined pricing, a focus on high quality care management, and a decline in medical cost. Aetna’s shares have outperformed the industry year to date. We expect the company to witness long-term growth from its Government business and International expansion. Its cost-reduction initiatives will aid margins. The sale of its Group Life and Disability business will help it to focus on core growth areas. Following strong third-quarter results, Aetna raised its earnings guidance, cementing investors' confidence in it. Aetna has, however, been incurring losses in its public exchange business and has been exiting exchanges. Furthermore, its membership growth remains under pressure. Increasing medical benefit ratios are also likely to hurt margins." (11/2/2017)
- 2. Cantor Fitzgerald analysts commented, "There is life after Humana. CEO Mark Bertolini opened the meeting discussing life after Humana. With a continued focus to grow its government business, Mr. Bertolini indicated that Humana represented a means to an end." Instead, AET will now chose to build its government business organically. We believe the company will also pursue acquisitions to build out its capabilities in specific geographies. CFO Shawn Guertin identified Medicare as a great growth opportunity, but characterized Medicaid as a good opportunity. Growth in Medicaid slowed recently due to two contract losses and potential for structural changes to Medicaid exist." (5/12/2017)
- 3. Royal Bank of Canada analysts commented, "After the close on Monday, April 24, Humana pre-released 1Q17 EPS ahead of its investor meeting, which will be held on Tuesday, April 25. 1Q17 Adjusted EPS for the quarter was $2.75 vs. our estimate of $2.50 and FactSet consensus of $2.49." (4/24/2017)
- 4. Oppenheimer Holdings Inc. analysts commented, "Overall, we believe Humana is well positioned for growth, given the political support in Washington, ample strategic capital to deploy and the potential for upside to its current earnings base."Ultimately, this will also remain a desirable asset that could be acquired by another insurer." (3/31/2017)
Who are some of Aetna's key competitors?
Who are Aetna's key executives?
Aetna's management team includes the folowing people:
- Mark T. Bertolini, Chairman of the Board, Chief Executive Officer (Age 60)
- Karen S. Lynch, President (Age 54)
- Shawn M. Guertin, Chief Financial Officer, Executive Vice President, Chief Enterprise Risk Officer (Age 53)
- Thomas J. Sabatino Jr., Executive Vice President, General Counsel (Age 58)
- Gary W. Loveman Ph.D., Executive Vice President - Consumer and Health Services (Age 56)
- Margaret M. McCarthy, Executive Vice President - Operations and Technology (Age 63)
- Harold L. Paz M.D., Executive Vice President, Chief Medical Officer (Age 62)
- Francis S. Soistman Jr., Executive Vice President - Government Services (Age 60)
- Heather Dixon, Chief Accounting Officer, Vice President, Controller (Age 45)
- Edward J. Ludwig, Lead Independent Director (Age 65)
Who owns Aetna stock?
Aetna's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Schwab Charles Investment Management Inc. (0.38%), Acadian Asset Management LLC (0.20%), Bank of Montreal Can (0.14%), Gateway Investment Advisers LLC (0.09%), National Pension Service (0.09%) and Chevy Chase Trust Holdings Inc. (0.09%). Company insiders that own Aetna stock include Francis S Soistman Jr, Gary W Loveman, Jeffrey E Garten, Karen S Lynch, Margaret M Mccarthy, Mark T Bertolini, Molly Joel Coye and Shawn M Guertin. View Institutional Ownership Trends for Aetna.
Who sold Aetna stock? Who is selling Aetna stock?
Aetna's stock was sold by a variety of institutional investors in the last quarter, including Atalanta Sosnoff Capital LLC, Sit Investment Associates Inc., DnB Asset Management AS, Westpac Banking Corp, Profit Investment Management LLC, Exxonmobil Investment Management Inc. TX, Chevy Chase Trust Holdings Inc. and Oakbrook Investments LLC. Company insiders that have sold Aetna company stock in the last year include Francis S Soistman Jr, Karen S Lynch, Margaret M Mccarthy, Mark T Bertolini and Shawn M Guertin. View Insider Buying and Selling for Aetna.
Who bought Aetna stock? Who is buying Aetna stock?
Aetna's stock was purchased by a variety of institutional investors in the last quarter, including Milestone Resources Group Ltd, Bank of Montreal Can, Factory Mutual Insurance Co., Acadian Asset Management LLC, Omni Partners LLP, KAMES CAPITAL plc, Schwab Charles Investment Management Inc. and State of Alaska Department of Revenue. View Insider Buying and Selling for Aetna.
How do I buy Aetna stock?
Shares of Aetna can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Aetna's stock price today?
One share of Aetna stock can currently be purchased for approximately $189.34.
How big of a company is Aetna?
Aetna has a market capitalization of $61.74 billion and generates $63.16 billion in revenue each year. The company earns $2.27 billion in net income (profit) each year or $5.41 on an earnings per share basis. Aetna employs 49,500 workers across the globe.
How can I contact Aetna?
Aetna's mailing address is 151 Farmington Ave, HARTFORD, CT 06156-0001, United States. The company can be reached via phone at +1-860-2730123 or via email at [email protected]
MarketBeat Community Rating for Aetna (AET)MarketBeat's community ratings are surveys of what our community members think about Aetna and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Aetna (NYSE:AET) Analysts' Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Buy||Buy||Buy||Buy|
|Consensus Rating Score: ||2.62||2.52||2.63||2.70|
|Ratings Breakdown: ||0 Sell Rating(s)|
8 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
10 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
7 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
6 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
|Consensus Price Target: ||$178.59||$178.71||$163.69||$153.24|
|Price Target Upside: ||4.91% downside||0.05% downside||0.73% upside||1.16% downside|
Aetna (NYSE:AET) Consensus Price Target History
Aetna (NYSE:AET) Analyst Ratings History
(Data available from 1/22/2016 forward)
Aetna (NYSE:AET) Earnings History and Estimates Chart
Aetna (NYSE AET) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|10/31/2017||Q3 2017||$2.06||$2.45||$15.12 billion||$14.99 billion||View||N/A|
|8/3/2017||Q2 2017||$2.34||$3.42||$15.34 billion||$15.52 billion||View||Listen|
|5/2/2017||Q1 2017||$2.36||$2.71||$15.39 billion||$15.17 billion||View||Listen|
|1/31/2017||Q416||$1.44||$1.63||$15.84 billion||$15.73 billion||View||Listen|
|10/27/2016||Q316||$2.02||$2.07||$15.71 billion||$15.78 billion||View||Listen|
|8/2/2016||Q216||$2.12||$2.21||$15.69 billion||$15.95 billion||View||Listen|
|4/28/2016||Q116||$2.23||$2.30||$15.46 billion||$15.69 billion||View||Listen|
|2/1/2016||Q415||$1.21||$1.37||$14.93 billion||$15.09 billion||View||Listen|
|10/29/2015||Q315||$1.77||$1.90||$15.22 billion||$15.00 billion||View||Listen|
|8/4/2015||Q215||$1.82||$2.05||$15.43 billion||$15.13 billion||View||Listen|
|4/28/2015||Q115||$1.96||$2.39||$15.48 billion||$15.09 billion||View||Listen|
|2/3/2015||Q414||$1.22||$1.22||$14.59 million||$14.77 million||View||Listen|
|10/28/2014||Q214||$1.58||$1.79||$14.63 billion||$14.70 billion||View||Listen|
|7/29/2014||Q114||$1.61||$1.69||$13.98 billion||$14.50 billion||View||Listen|
|4/24/2014||Q413||$1.56||$1.98||$13.69 billion||$13.97 billion||View||Listen|
|2/6/2014||Q313||$1.36||$1.34||$13.14 billion||$13.13 billion||View||Listen|
|10/29/2013||Q213||$1.53||$1.53||$12.89 billion||$12.99 billion||View||Listen|
|7/30/2013||Q2 2013||$1.39||$1.52||$12.02 billion||$11.56 billion||View||Listen|
|4/30/2013||Q1 2013||$1.38||$1.50||$9.65 billion||$9.51 billion||View||Listen|
|1/31/2013||Q4 2012||$0.96||$0.94||$8.97 billion||$8.96 billion||View||Listen|
|10/25/2012||Q312||$1.34||$1.55||$8.96 billion||$8.90 billion||View||N/A|
Aetna (NYSE:AET) Earnings Estimates
2018 EPS Consensus Estimate: $10.69
2019 EPS Consensus Estimate: $11.11
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Aetna (NYSE:AET) Dividend Information
|Dividend Growth:||24.80% (3 Year Average)|
|Payout Ratio:||36.97% (Trailing 12 Months of Earnings) |
20.45% (Based on This Year's Estimates)
18.99% (Based on Next Year's Estimates)
Aetna (NYSE:AET) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Aetna (NYSE AET) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.14%
Institutional Ownership Percentage: 87.88%
Aetna (NYSE AET) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|9/18/2017||Karen S Lynch||President||Sell||15,271||$161.91||$2,472,527.61||64,261|| |
|9/15/2017||Margaret M Mccarthy||EVP||Sell||10,288||$162.85||$1,675,400.80||33,563|| |
|6/7/2017||Margaret M Mccarthy||EVP||Sell||27,028||$149.23||$4,033,388.44||33,563|| |
|5/17/2017||Mark T Bertolini||Chairman||Sell||103,547||$140.79||$14,578,382.13||659,888|| |
|3/23/2017||Shawn M Guertin||Insider||Sell||29,602||$129.35||$3,829,018.70||44,880|| |
|3/8/2017||Francis S Soistman Jr||VP||Sell||6,607||$131.98||$871,991.86||23,454|| |
|9/7/2016||Jeffrey E. Garten||Director||Sell||7,100||$116.51||$827,221.00|| |
|8/23/2016||Shawn M Guertin||Insider||Sell||45,328||$120.21||$5,448,878.88||44,883|| |
|5/10/2016||Margaret M Mccarthy||EVP||Sell||39,169||$114.45||$4,482,892.05||56,240|| |
|5/3/2016||Mark T Bertolini||CEO||Sell||33,510||$114.00||$3,820,140.00||496,588|| |
|3/15/2016||Gary W Loveman||EVP||Buy||8,970||$111.45||$999,706.50||9,605|| |
|2/22/2016||Molly Joel Coye||Director||Sell||1,175||$106.28||$124,879.00||8,104|| |
|12/23/2015||Margaret M Mccarthy||EVP||Sell||18,373||$109.97||$2,020,478.81||63,515|| |
|12/22/2015||Mark T. Bertolini||CEO||Sell||26,996||$110.00||$2,969,560.00||729,194|| |
|8/14/2015||Joseph M Zubretsky||EVP||Sell||179,087||$118.66||$21,250,463.42|| |
|8/13/2015||Franklin Barbara Hackman||Director||Sell||2,064||$118.47||$244,522.08|| |
|3/31/2015||Joseph M Zubretsky||EVP||Sell||200,000||$107.96||$21,592,000.00|| |
|3/27/2015||Joseph M Zubretsky||EVP||Sell||86,958||$107.24||$9,325,375.92|| |
|3/26/2015||Joseph M Zubretsky||Insider||Sell||162,066||$106.98||$17,337,820.68|| |
|3/26/2015||Margaret M Mccarthy||EVP||Sell||27,670||$106.04||$2,934,126.80|| |
|3/25/2015||Franklin Barbara Hackman||Director||Sell||3,000||$108.75||$326,250.00|| |
|3/17/2015||William James Casazza||VP||Sell||14,000||$105.07||$1,470,980.00|| |
|3/2/2015||Molly Joel Coye||Director||Sell||2,500||$100.27||$250,675.00|| |
|2/10/2015||Rajan Parmeswar||VP||Sell||5,300||$95.60||$506,680.00|| |
|6/16/2014||Molly Joel Coye||Director||Sell||1,650||$80.60||$132,990.00|| |
|6/12/2014||William James Casazza||VP||Sell||15,906||$80.58||$1,281,705.48|| |
|5/27/2014||Franklin Barbara Hackman||Director||Sell||2,665||$77.26||$205,897.90|| |
|2/19/2014||Rajan Parmeswar||VP||Sell||3,600||$69.46||$250,056.00||3,829|| |
|12/30/2013||Mark Bertolini||CEO||Sell||130,272||$68.08||$8,868,917.76||526,938|| |
|12/27/2013||William James Casazza||VP||Sell||10,299||$68.25||$702,906.75||33,903|| |
|8/26/2013||William James Casazza||VP||Sell||15,745||$64.66||$1,018,071.70||33,903|| |
|6/18/2013||William James Casazza||VP||Sell||40,598||$62.00||$2,517,076.00|| |
|5/21/2013||Molly Joel Coye||Director||Sell||2,000||$60.38||$120,760.00|| |
|5/20/2013||Joseph P Newhouse||Director||Sell||14,000||$59.15||$828,100.00|| |
|5/15/2013||Rajan Parmeswar||VP||Sell||1,435||$60.13||$86,286.55|| |
|2/6/2013||Karen Rohan||VP||Buy||4,035||$49.53||$199,853.55|| |
Aetna (NYSE AET) News Headlines
|Lifshitz & Miller LLP Announces Investigation of Aetna Inc., AZZ Inc., Barracuda Networks, Inc., Bill Barrett ... - PR Newswire (press release)|
www.prnewswire.com - January 20 at 7:04 AM
|Lifshitz & Miller LLP Announces Investigation of Aetna Inc., AZZ Inc., Barracuda Networks, Inc., Bill Barrett Corporation, Blackhawk Network Holdings, Inc., Capitala Finance Corp., and Ekso Bionics Holdings, Inc.|
finance.yahoo.com - January 20 at 7:04 AM
|SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit In Connection With The Sale Of Aetna, Inc. (NYSE:AET)|
finance.yahoo.com - January 19 at 8:50 AM
|BRIEF-Aetna Enhances Accountable Care Product In Connecticut With Trinity Health Of New England|
www.reuters.com - January 18 at 3:23 PM
|Why the amount of Americans with no insurance is growing|
finance.yahoo.com - January 18 at 3:23 PM
| Analysts Anticipate Aetna Inc (AET) Will Announce Quarterly Sales of $14.89 Billion|
www.americanbankingnews.com - January 18 at 9:40 AM
|Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Aetna, Inc In The District Of ... - PR Newswire (press release)|
www.prnewswire.com - January 18 at 7:52 AM
|Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Aetna, Inc In The District Of Connecticut|
finance.yahoo.com - January 18 at 7:52 AM
|Aetna Inc (AET) Expected to Post Q1 2019 Earnings of $3.03 Per Share|
www.americanbankingnews.com - January 17 at 10:44 PM
|Big Five MCOs on Pace to Beat Market in Medicare Advantage Growth for January|
finance.yahoo.com - January 17 at 3:23 PM
|Aetna to pay $17M over mailing that revealed HIV meds|
marketbeat.com - January 17 at 1:46 PM
|Aetna to Announce Fourth-Quarter and Full-Year 2017 Results|
finance.yahoo.com - January 17 at 11:37 AM
|Aetna Inc (AET) Given Consensus Rating of "Buy" by Analysts|
www.americanbankingnews.com - January 16 at 1:38 AM
|Aetna Inc (AET) Forecasted to Post Q1 2018 Earnings of $2.80 Per Share|
www.americanbankingnews.com - January 15 at 5:40 AM
|CVS plans to keep Aetna's headquarters in Connecticut|
finance.yahoo.com - January 12 at 3:21 PM
|CVS says it will keep Aetna in Connecticut's capital city|
marketbeat.com - January 12 at 1:09 PM
|Aetna Target of Unusually High Options Trading (AET)|
www.americanbankingnews.com - January 12 at 1:28 AM
|BRIEF-Aetna Says California Department Of Health Care Services Approves Aetna's Participation In Medi-Cal|
www.reuters.com - January 11 at 3:23 PM
|Amid N.C.’s Medicaid reform, Aetna inks agreement with CCNC|
finance.yahoo.com - January 11 at 3:23 PM
|Introducing Aetna Better Health® of California|
finance.yahoo.com - January 11 at 3:23 PM
|Vitality Re IX $200m Health ILS From Aetna The First Deal Of 2018 - Seeking Alpha|
seekingalpha.com - January 11 at 7:21 AM
|New York City Halts $9.6 Million Incentive Package for Aetna Headquarters - Wall Street Journal|
www.wsj.com - January 11 at 7:21 AM
|NYC halts $9.6M incentive package to move Aetna to city|
marketbeat.com - January 10 at 10:03 PM
|AETNA Inc. Issues Positive Coverage Decision for ThyroSeq® Thyroid Genomic Classifier|
www.prnewswire.com - January 10 at 3:23 PM
|Aetna Inc. (AET) Ex-Dividend Date Scheduled for January 10, 2018 - Nasdaq|
www.nasdaq.com - January 10 at 7:44 AM
|AbleTo, Inc. Announces James P. Bradley as Chairman of the Board|
www.prnewswire.com - January 9 at 3:22 PM
|CVS Could Climb Another 13% in '18: Morgan Stanley - Investopedia (blog)|
www.investopedia.com - January 9 at 7:57 AM
|Contrasting Aetna (AET) & Coventry Health Care (CVH)|
www.americanbankingnews.com - January 8 at 1:40 PM
|AET Ex-Dividend Reminder - 1/10/18 - Nasdaq|
www.nasdaq.com - January 8 at 11:12 AM
|Implied Volatility Surging for Aetna (AET) Stock Options - Nasdaq.com - Nasdaq|
www.nasdaq.com - January 6 at 3:22 PM
|Aetna Inc (NYSE:AET): Can It Deliver A Superior ROE To The Industry?|
finance.yahoo.com - January 6 at 7:48 AM
|CVS Health expects tax overhaul to boost cash flow, shares rise - Reuters|
www.reuters.com - January 5 at 7:27 AM
|Aetna and CVS Were Talking to Others During Takeover Process ... - Bloomberg|
www.bloomberg.com - January 5 at 7:27 AM
|Aetna and CVS Were Both Talking to Others During Deal Process|
finance.yahoo.com - January 5 at 7:27 AM
|Implied Volatility Surging for Aetna (AET) Stock Options|
finance.yahoo.com - January 4 at 3:22 PM
|Want To Invest In Aetna Inc (NYSE:AET)? Here’s How It Performed Lately|
finance.yahoo.com - January 4 at 7:28 AM
|UnitedHealth (UNH) Arm to Buy Chilean Company for $2.8B|
finance.yahoo.com - December 27 at 9:13 AM
|What Is Aetna Inc’s (NYSE:AET) Share Price Doing?|
finance.yahoo.com - December 27 at 9:13 AM
|Form 4 AETNA INC /PA/ For: Dec 19 Filed by: Jelinek Richard M|
www.streetinsider.com - December 22 at 3:39 PM
|Form 4 AETNA INC /PA/ For: Dec 19 Filed by: Jelinek Richard M - StreetInsider.com|
www.streetinsider.com - December 22 at 7:21 AM
|Aetna Inc (AET) Receives Consensus Rating of "Buy" from Analysts|
www.americanbankingnews.com - December 22 at 1:34 AM
|Aetna's $640 Million CEO Is Overpaid By $440 Million - Seeking Alpha|
seekingalpha.com - December 21 at 7:20 AM
|Aetna (AET) Lowered to "Equal" at Morgan Stanley|
www.americanbankingnews.com - December 20 at 12:08 PM
|Humana, private equity firms buy Kindred Healthcare for $810 mln|
finance.yahoo.com - December 20 at 7:12 AM
|RPT-U.S. employers say CVS-Aetna deal would affect health-benefits decisions -survey|
www.businessinsider.com - December 19 at 3:22 PM
|Insurer Humana pushes deeper into delivery of health care|
marketbeat.com - December 19 at 3:18 PM
|CVS CIO Stephen Gold Exits Ahead of Planned Aetna Acquisition|
finance.yahoo.com - December 18 at 3:22 PM
|U.S. employers say CVS-Aetna deal would affect health-benefits ... - Reuters|
www.reuters.com - December 17 at 3:21 PM
|Aetna Inc (AET) Expected to Post Quarterly Sales of $14.89 Billion|
www.americanbankingnews.com - December 15 at 6:24 AM
|Form 4 AETNA INC /PA/ For: Dec 11 Filed by: SOISTMAN FRANCIS S JR|
www.streetinsider.com - December 14 at 3:22 PM
Aetna (NYSE:AET) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Aetna (NYSE:AET) Income Statement, Balance Sheet and Cash Flow Statement
Aetna (NYSE AET) Stock Chart for Monday, January, 22, 2018